179 related articles for article (PubMed ID: 22028900)
1. Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera.
Wu Z; Yuan H; Zhang X; Liu W; Xu J; Zhang W; Guan M
PLoS One; 2011; 6(10):e26534. PubMed ID: 22028900
[TBL] [Abstract][Full Text] [Related]
2. Melting point assay for the JAK2 V617F mutation, comparison with amplification refractory mutation system (ARMS) in diagnostic samples, and implications for daily routine.
Ochsenreither S; Reinwald M; Thiel E; Burmeister T
Mol Diagn Ther; 2010 Jun; 14(3):185-90. PubMed ID: 20560681
[TBL] [Abstract][Full Text] [Related]
3. A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood.
Poodt J; Fijnheer R; Walsh IB; Hermans MH
Hematol Oncol; 2006 Dec; 24(4):227-33. PubMed ID: 17006961
[TBL] [Abstract][Full Text] [Related]
4. Toward point-of-care testing for JAK2 V617F mutation on a microchip.
Wang H; Liu W; Zhang X; Xu X; Kang Z; Li S; Wu Z; Yang Z; Yao B; Guan M
J Chromatogr A; 2015 Sep; 1410():28-34. PubMed ID: 26235214
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a tetra-primer amplification refractory mutation system-polymerase chain reaction combined with melting analysis-assay for clinical JAK2 V617F mutation detection.
Liu W; Hu T; Chen Y; Zhang X; Gu X; Guan M
Mol Diagn Ther; 2014 Oct; 18(5):579-85. PubMed ID: 25015634
[TBL] [Abstract][Full Text] [Related]
6. Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system.
Olsen RJ; Tang Z; Farkas DH; Bernard DW; Zu Y; Chang CC
Arch Pathol Lab Med; 2006 Jul; 130(7):997-1003. PubMed ID: 16831057
[TBL] [Abstract][Full Text] [Related]
7. Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera.
Nussenzveig RH; Burjanivova T; Salama ME; Ogilvie NW; Marcinek J; Plank L; Agarwal AM; Perkins SL; Prchal JT
Leuk Lymphoma; 2012 Dec; 53(12):2479-86. PubMed ID: 22642932
[TBL] [Abstract][Full Text] [Related]
8. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY
J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011
[TBL] [Abstract][Full Text] [Related]
9. Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.
Ugo V; Tondeur S; Menot ML; Bonnin N; Le Gac G; Tonetti C; Mansat-De Mas V; Lecucq L; Kiladjian JJ; Chomienne C; Dosquet C; Parquet N; Darnige L; Porneuf M; Escoffre-Barbe M; Giraudier S; Delabesse E; Cassinat B;
PLoS One; 2010 Jan; 5(1):e8893. PubMed ID: 20126644
[TBL] [Abstract][Full Text] [Related]
10. A tetra-primer polymerase chain reaction approach for the detection of JAK2 V617F mutation.
Koksal V; Etlik O; Arican-Baris ST; Baris I
Genet Test; 2007; 11(4):463-6. PubMed ID: 18294066
[TBL] [Abstract][Full Text] [Related]
11. Detection of acquired Janus kinase 2 V617F mutation in myeloproliferative disorders by fluorescence melting curve analysis.
Reading NS; Lim MS; Elenitoba-Johnson KS
Mol Diagn Ther; 2006; 10(5):311-7. PubMed ID: 17022694
[TBL] [Abstract][Full Text] [Related]
12. Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
Jones AV; Cross NC; White HE; Green AR; Scott LM
Haematologica; 2008 Oct; 93(10):1560-4. PubMed ID: 18698085
[TBL] [Abstract][Full Text] [Related]
13. Polycythemia vera is not initiated by JAK2V617F mutation.
Nussenzveig RH; Swierczek SI; Jelinek J; Gaikwad A; Liu E; Verstovsek S; Prchal JF; Prchal JT
Exp Hematol; 2007 Jan; 35(1):32-8. PubMed ID: 17198871
[TBL] [Abstract][Full Text] [Related]
14. Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques.
Veneri D; Capuzzo E; de Matteis G; Franchini M; Baritono E; Benati M; Solero GP; Ambrosetti A; Quaresmini G; Pizzolo G
Blood Transfus; 2009 Jul; 7(3):204-9. PubMed ID: 19657484
[TBL] [Abstract][Full Text] [Related]
15. Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis.
Cao HC; Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF
J Clin Lab Anal; 2011; 25(4):300-4. PubMed ID: 21786333
[TBL] [Abstract][Full Text] [Related]
16. Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation.
Wolstencroft EC; Hanlon K; Harries LW; Standen GR; Sternberg A; Ellard S
J Mol Diagn; 2007 Feb; 9(1):42-6. PubMed ID: 17251334
[TBL] [Abstract][Full Text] [Related]
17. Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.
Leszczynska A; Grzenkowicz-Wydra J; Chmielewska-Gorycka L; Bieniaszewska M; Hellmann A
Acta Haematol; 2016; 136(2):123-8. PubMed ID: 27410038
[TBL] [Abstract][Full Text] [Related]
18. Methods for detecting mutations in the human JAK2 gene.
Bench AJ; Baxter EJ; Green AR
Methods Mol Biol; 2013; 967():115-31. PubMed ID: 23296725
[TBL] [Abstract][Full Text] [Related]
19. Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis.
Sutton BC; Allen RA; Zhao ZJ; Dunn ST
Cancer Biomark; 2007; 3(6):315-24. PubMed ID: 18048969
[TBL] [Abstract][Full Text] [Related]
20. Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting.
Lin CY; Ho CM; Tamamyan G; Yang SF; Peng CT; Chang JG
J Clin Lab Anal; 2016 Nov; 30(6):838-844. PubMed ID: 27169616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
